Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent B… (NCT05320718) | Clinical Trial Compass
CompletedNot Applicable
Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block
China140 participantsStarted 2022-04-15
Plain-language summary
Paravertebral block (PVB) has been regarded as effective regimen for pain control after cardiac surgery. As a novel analgesia technique, erector spinae plane block (ESPB) has been reported to provide effective analgesia after thoracic and cardiac surgery. We hypothesized that the ESPB is non-inferior to PVB in treating pain in minimally invasive direct coronary artery bypass surgery.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Exclusion criteria
. Contraindications to regional anesthesia (coagulopathy, infection of the skin at the site of needle puncture area, et al)
. Morbid obesity (body mass index \> 35 kg/m2)
. Allergy to any of the study drugs
. Chronic opioid use or history of opioid abuse.
. Inability to understand pain score
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial compared two nerve block techniques — erector spinae plane block and paravertebral block — for pain control after minimally invasive heart bypass surgery; which of these approaches does your surgical team currently use, and do the results of this completed study influence how you manage pain after this type of procedure?
2Since the trial specifically measured pain during coughing after surgery, which can be a real challenge after chest operations, how well do the pain control methods used at this hospital handle that particular type of movement-related pain?
3The trial tracked how much additional pain medication patients needed after surgery; based on what this study found, would I be likely to need significant rescue pain medication, and what would that look like in practice during my recovery?
4Because this was a study focused on regional anesthesia techniques rather than testing a new drug or device, does it change the usual standard of care I would receive, or are these nerve blocks already a routine part of minimally invasive bypass surgery here?
5Since the trial is now completed, have the results been published yet, and is there anything in the findings that might affect which pain management approach you would recommend for my specific situation?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.